5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)thieno[2,3-b]pyridine, 96.0%, 1g

Indole-7-boronic acid, 95.0%, 250mg

Benzyl 4-Hydroxypiperidine-1-carboxylate, 97.0%, 500g

5-(4-Methoxyphenyl)pyridin-2(1H)-one, 95.0%, 250mg

ETHYL 3-ETHYNYL-4-FLUOROBENZOATE, 95.0%, 250mg

Methyl o-tolylacetate, 98.0%, 1g

1,4-dioxano, mínimo 99,5 %, para síntesis, estabilizado, 500 ml, envase de vidrio

(S)-tert-Butyl 2-(aminomethyl)azetidine-1-carboxylate, 95.0%, 1g

(S)-7-(3-aminopyrrolidin-1-yl)-N,N-dimethylbenzo[c][1,2,5]oxadiazole-4-sulfonamide, 98%, 100mg

Methyl 6-bromo-2-oxo-1,2-dihydropyridine-3-carboxylate, 95%, 250mg

3,5-Dichloro-2-hydroxybenzaldehyde, 90.0%, 10g

(2R,3R)-Dibenzyl 2,3-dihydroxysuccinate, 95%, 25g

4-Chloro-2-fluoro-3-methoxyphenol, 95%, 500mg